CD8A and melanoma: The importance of MHC-I was validated by examining autologous CD8+ T cell activation (IFNγ+/CD107+ CD8+ T cells) in the presence or absence of MHC-I blocking antibody in co-culture experiments with two MHC-I positive melanoma cell models (Fig. 5F).